50.45
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 | 2023-12-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.98%
321.39
|
345.51 | 336.17 | 343.29 | 336.25 |
| Cost Of Revenue |
18.30%
129.15
|
158.07 | 161.25 | 167.38 | 158.38 |
| Gross Profit |
2.56%
192.24
|
187.44 | 174.92 | 175.91 | 177.87 |
|
|
1.94%
138.37
|
135.74 | 135.17 | 145.96 | 131.89 |
| Benefits Costs and Expenses |
8.17%
276.23
|
300.81 | 289.46 | 319.88 | 292.22 |
| Costs And Expenses |
8.17%
276.23
|
300.81 | 289.46 | 319.88 | 292.22 |
| Depreciation and Amortization |
1.57%
28.76
|
29.22 | 29.14 | 27.64 | 23.53 |
| Operating Income/Loss |
4.21%
53.87
|
51.70 | 39.76 | 29.94 | 45.98 |
| Income/Loss From Continuing Operations Before Tax |
1.04%
45.17
|
44.70 | 46.71 | 23.41 | 44.03 |
| Income Tax Expense/Benefit, Deferred |
-3.231
|
- | - | - | - |
| Income Tax Expense/Benefit |
2.44%
11.14
|
10.87 | 8.34 | 3.047 | 12.79 |
| Income/Loss From Continuing Operations After Tax |
0.59%
34.03
|
33.83 | 38.37 | 20.37 | 31.24 |
|
|
0.59%
34.03
|
33.83 | 38.37 | 20.37 | 31.24 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5.48%
48.11
|
50.90 | 50.94 | 0.027 | 50.77 |
| Diluted Average Shares |
5.63%
48.35
|
51.24 | 51.56 | 0.003 | 51.45 |
| Basic Earnings Per Share |
7.58%
0.71
|
0.66 | 0.75 | 0.40 | 0.62 |
| Diluted Earnings Per Share |
6.06%
0.70
|
0.66 | 0.74 | 0.40 | 0.61 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):